PECOHorizontalLogoBlue.png
Phillips Edison & Company Inc. Invites You to Join Its Fourth Quarter and Full Year 2024 Earnings Conference Call
January 08, 2025 16:06 ET | Phillips Edison & Company, Inc.
CINCINNATI, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Phillips Edison & Company, Inc. (Nasdaq: PECO) (“PECO” or the “Company”), one of the nation’s largest owners and operators of high-quality,...
GLDDcorp_Bullseye (4).jpg
Great Lakes Announces Election of New Director
January 08, 2025 16:05 ET | Great Lakes Dredge & Dock Corporation
HOUSTON, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Great Lakes Dredge & Dock Corporation ("Great Lakes" or the “Company”) (NASDAQ: GLDD), the largest provider of dredging services in the United...
logo.jpg
Saratoga Investment Corp. Announces Fiscal Third Quarter 2025 Financial Results
January 08, 2025 16:05 ET | Saratoga Investment Corp
Reports 1.1% Sequential Quarter Increase in Adjusted NII per Share (Excluding the Effect of the One-Time Interest Reserve Reversal) and Grows LTM ROE to 9.2% Reports...
PP_InvestmentCorporation_RGB copy.jpg
PennantPark Investment Corporation Schedules Earnings Release of First Fiscal Quarter 2025 Results
January 08, 2025 16:05 ET | PennantPark Investment Corporation
MIAMI, Jan. 08, 2025 (GLOBE NEWSWIRE) -- PennantPark Investment Corporation (the "Company") (NYSE: PNNT) announced that it will report results for the first fiscal quarter ended December 31, 2024 on...
DyneLogo_R_FINAL_FULL_COLOR_RGB.jpg
Dyne Therapeutics to Host Investor Conference Call and Webcast to Review New Clinical Data from the ACHIEVE Trial Friday, January 10 at 8:00 a.m. ET
January 08, 2025 16:05 ET | Dyne Therapeutics, Inc.
WALTHAM, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage neuromuscular disease company focused on advancing innovative life-transforming therapeutics...
Nasdaq.jpg.prdesk.globenewswire.jpg
Nasdaq Reports December 2024 Volumes and 4Q24 Statistics
January 08, 2025 16:05 ET | Nasdaq, Inc.
NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for December 2024, as well as quarterly volumes, estimated revenue capture, number of listings, and...
solid-1029x579.png
Solid Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 08, 2025 16:05 ET | Solid Biosciences Inc.
CHARLESTOWN, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for...
Zymeworks Logo_color.png
Zymeworks Outlines Strategic Priorities and Outlook for 2025 and 2026
January 08, 2025 16:05 ET | Zymeworks Inc.
Investigational new drug (IND) applications for initiating first-in-human studies for ZW220 and ZW251 in solid tumors anticipated in 2025IND applications for initiating first-in-human studies for...
Sana Biotechnology.jpg
Sana Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 08, 2025 16:05 ET | Sana Biotechnology, Inc
SEATTLE, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will...
01-sprout-social-logo-lockup-MAIN-4x.png
Sprout Social to Announce Fourth Quarter 2024 Financial Results on February 25, 2025
January 08, 2025 16:05 ET | Sprout Social, Inc
CHICAGO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Sprout Social, Inc. (“Sprout Social”, the “Company”) (Nasdaq: SPT), an industry-leading provider of cloud-based social media management software, today...